Serine

Serine

SCHEMBL7384366

N[C@@H](CO)C(=O)O.O=C(O)CCN[C@H](CCc1ccccc1)C(=O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GGT1 P19440 3/20 0.48
MME P08473 1/20 0.44
ACE P12821 1/20 0.43
GRIK1 P39086 2/20 0.43
NAALAD2 Q9Y3Q0 1/20 0.42
ALPI P09923 1/20 0.42
PKM P14618 1/20 0.42
PTGS1 P23219 1/20 0.42
XIAP P98170 1/20 0.42
SLC7A5 Q01650 1/20 0.42
KEAP1 Q14145 1/20 0.41
SLC15A1 P46059 1/20 0.40
LTA4H P09960 1/20 0.40
HDAC3 O15379 1/20 0.40
MAPK1 P28482 1/20 0.40
ADRA1A P35348 1/20 0.40
HDAC4 P56524 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HDAC1 Q13547 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Homophenylalanine SCHEMBL7383933 0.92 GGT1 (0.50) GGT1MMEACEGRIK1NAALAD2
Glutamic Acid SCHEMBL7375280 0.91 GGT1 (0.49) GGT1MMEACEGRIK1NAALAD2
Phenylalanine SCHEMBL7432097 0.90 ALPI (0.56) GGT1MMEACENAALAD2ALPI
SCHEMBL6423726 0.89 GGT1 (0.57) GGT1MMEACENAALAD2KEAP1
SCHEMBL7383218 0.89 GGT1 (0.53) GGT1MMEACEGRIK1NAALAD2
Serine SCHEMBL7381496 0.88 SLC1A3 (0.45) GRIK1LTA4HFOLH1
Asparagine SCHEMBL7375839 0.88 GGT1 (0.46) GGT1MMEACEGRIK1NAALAD2
Alanine SCHEMBL7382718 0.87 GGT1 (0.50) GGT1MMEACENAALAD2PKM
Ornithine SCHEMBL7376158 0.86 GGT1 (0.48) GGT1MMEACEGRIK1LTA4H
Leucine SCHEMBL6415294 0.86 LTA4H (0.46) GGT1MMEGRIK1PKMSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063991-A1 STATIN-MATRIX METALLOPROTEINASE INHIBITOR COMBINATIONS WARNER-LAMBERT COMPANY LLC (US) 2001-01-03 EP disclosed
EP-0946166-A1 USE OF MATRIX METALLOPROTEINASE INHIBITORS FOR TREATING NEUROLOGICAL DISORDERS AND PROMOTING WOUND HEALING WARNER-LAMBERT COMPANY (US) 1999-10-06 EP disclosed
WO-1999047138-A1 STATIN-MATRIX METALLOPROTEINASE INHIBITOR COMBINATIONS WARNER-LAMBERT COMPANY (US) 1999-09-23 WO disclosed
WO-1998026773-A1 USE OF MATRIX METALLOPROTEINASE INHIBITORS FOR TREATING NEUROLOGICAL DISORDERS AND PROMOTING WOUND HEALING WARNER-LAMBERT COMPANY (US) 1998-06-25 WO disclosed